FDAnews Device Daily Bulletin

CABRINI PERFORMS FIRST HIFU SONABLATE 500 PROCEDURE WITH TELE-REMOTE TREATMENT OF PROSTATE CANCER IN MELBOURNE

Dec. 8, 2005
A A

Meditron Pty., Ltd. Today announced that the first ever HIFU (High Intensity Focused Ultrasound) surgery with tele-remote link to an academic institution was performed for the treatment of prostate cancer at Cabrini Medical Centre. Cabrini Medical Centre in Melbourne is a leading institution for prostate cancer treatment in Australia. The Sonablate(R) 500 uses advanced HIFU energy which is sharply focused and destroys targeted prostate tissue without affecting the intervening tissue.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/12-02-2005/0004226967&EDATE=)